Dr. Reddy's Laboratories Limited (RDDA) — Capital Reinvestment Ratio
Dr. Reddy's Laboratories Limited (RDDA) has a Capital Reinvestment Ratio of 0.67x as of December 2025, meaning it reinvests 1% of its operating cash flow (€10.91 Billion) in capital expenditures (€7.32 Billion). See cash generation quality of Dr. Reddy's Laboratories Limited to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Dr. Reddy's Laboratories Limited Capital Reinvestment Ratio (2017–2025)
This chart tracks Dr. Reddy's Laboratories Limited's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Dr. Reddy's Laboratories Limited (2017–2025)
Year-by-year Capital Reinvestment Ratio for Dr. Reddy's Laboratories Limited from 2017 to 2025. For live market cap and broader valuation context, see market value of Dr. Reddy's Laboratories Limited.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.74x | €46.43 Billion | €34.40 Billion | ▲ +22.7% |
| 2024 | 0.60x | €45.43 Billion | €27.43 Billion | ▲ +88.4% |
| 2023 | 0.32x | €58.88 Billion | €18.87 Billion | ▼ -38.6% |
| 2022 | 0.52x | €28.11 Billion | €14.66 Billion | ▲ +91.2% |
| 2021 | 0.27x | €35.70 Billion | €9.74 Billion | ▲ +68.0% |
| 2020 | 0.16x | €29.84 Billion | €4.85 Billion | ▼ -33.0% |
| 2019 | 0.24x | €28.70 Billion | €6.96 Billion | ▼ -53.0% |
| 2018 | 0.52x | €18.03 Billion | €9.29 Billion | ▼ -9.7% |
| 2017 | 0.57x | €21.51 Billion | €12.28 Billion | — |